• Zentalis Pharmaceuticals granted non-qualified stock options for 191,000 shares to two newly hired employees under its 2022 Employment Inducement Incentive Award Plan.
• Options were priced at USD 3.98 per share, matching the Nasdaq close on June 1, 2026.
• Awards carry a 10-year term with four-year vesting; 25% vests after one year, remainder vests monthly over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606011700PRIMZONEFULLFEED9730013) on June 01, 2026, and is solely responsible for the information contained therein.